Product Approval Information

Proper Name: Hepatitis B Vaccine (Recombinant)
Tradename: RECOMBIVAX HB
Manufacturer: Merck & Co, Inc, License #0002

Package Insert (PDF - 126 KB) - Approved: May 15, 2007

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.


Date: September 23, 1999
Labeling Supplement: Addition of two doses of the 10 mcg formulation (1.0 mL) administered at 0 and 4 to 6 months as an alternate regimen for the routine vaccination of healthy adolescents 11 to 15 years of age
September 23, 1999 Approval Letter

Date: August 27, 1999
Manufacturing Change: Preservative-free pediatric/adolescent product
August 27, 1999 Approval Letter

Summary for Basis of Approval (PDF - 863 KB)

 
Updated: January 31, 2008